Paris - the founder and majority shareholder of Bio-Access, Jean-Louis Oger, announced announce that he's signed today, alongside its shareholders and executives, an agreement with Eurofins Scientific the leading global provider in the market for bio-analysis and one of the world leader in genomic services for the control Group assignment. Several current shareholders of Bio-Access, biologists and managers co-invest alongside Eurofins and Jean-Louis Oger.
The Mayer Brown team included:
- Jean-François Louit, partner
- Alexandre Dejardin, partner
- Caroline Lan, associate
- Jérémy Thézée, associate
- Barbara Petrovic, associate.
News
-
May/June 2020
Stay up-to-date on our perspectives
Subscribe to Email